Vaccines

COVID-19 Vaccines COVID-19 MMR Vaccine Vaccine Development Vaccine Safety Respiratory Syncytial Virus (RSV) Covid Vaccines Covid-19 Vaccines COVID-19 Vaccine mRNA Technology

Moderna Reaches Up to $2.25 Billion LNP Patent Settlement, Pays $950 Million Upfront

The settlement grants Moderna a global license with no royalties, leaving a narrow government‑liability appeal as the only remaining issue.

Autism Researchers Launch Independent Panel to Counter RFK Jr.’s Overhauled Federal Committee

WHO Sets 2026 Flu Vaccine Strains for Northern Hemisphere After H3N2 Variant Gains Ground

U.S. Confidence in MMR, Flu and Covid Vaccines Slips, Survey Finds

CSL Profit Slides on Plasma Weakness as Buyback Hits $750 Million, Interim CEO Appointed

Merck Lifts Mid-2030s Revenue Goal to $70 Billion From Emerging Businesses

Dupixent Powers Sanofi’s Q3 as Vaccine Sales Slip

Merck Wins FDA Approval for Subcutaneous Keytruda as EU Panel Backs Infant RSV Preventive

Health Officials Rebuke Trump’s MMR Claims as UK Pharmacies Report Hesitancy

Greene Urges DOJ to Drop Charges Against Surgeon on Trial for COVID-19 Vaccine Fraud

UK Health Agency Warns of Measles Surge Ahead of Glastonbury

Federal Investigation Examines Claims of Pfizer Vaccine Announcement Delay in 2020

Pfizer Reports Strong Q4 Earnings But Faces Uncertain Market Sentiment

Pfizer Exceeds Q4 Earnings Expectations with Strong Covid Product Sales and Cost Cuts

AstraZeneca Cancels £450m UK Vaccine Plant Expansion Over Funding Dispute

Trust in U.S. Public Health Agencies Declines as RFK Jr. Faces Confirmation Hearings

New XEC COVID Variant Emerges in UK, Raising Hospitalisation Rates

New COVID Surge and Updated Vaccines Prompt Renewed Precautions

Moderna Secures $176M to Develop mRNA Bird Flu Vaccine

CDC Recommends Updated Vaccines for Fall 2024